May 28, 2026 08:05AM
May 13, 2026 08:00AM
May 12, 2026 04:01PM
May 5, 2026 04:06PM
May 5, 2026 04:05PM
May 5, 2026 08:00AM
Apr 9, 2026 04:05PM Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Inves
Apr 6, 2026 08:00AM
Mar 11, 2026 08:00AM
Mar 5, 2026 08:00AM
Feb 23, 2026 08:00AM
Feb 12, 2026 08:00AM
Feb 12, 2026 08:00AM
Feb 9, 2026 08:03AM Verrica partner launches YCANTH molluscum treatment in Japan
Feb 9, 2026 08:00AM
Jan 7, 2026 11:34AM
Jan 7, 2026 08:00AM
Jan 7, 2026 08:00AM
Nov 24, 2025 08:00AM
Nov 24, 2025 08:00AM
Nov 14, 2025 04:05PM Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
Nov 10, 2025 08:00AM
Nov 10, 2025 08:00AM
Nov 5, 2025 06:36AM
Oct 20, 2025 04:06PM
Oct 20, 2025 04:05PM
Oct 7, 2025 04:05PM
Oct 7, 2025 04:05PM Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Sep 19, 2025 08:02AM
Sep 19, 2025 08:00AM
Sep 2, 2025 07:00AM
Aug 12, 2025 04:01PM
Aug 12, 2025 04:01PM
Aug 6, 2025 07:00AM
Jul 9, 2025 07:02AM Verrica reports 32.8% quarterly growth in YCANTH applicator units
Jul 9, 2025 07:00AM
Jul 1, 2025 07:00AM
Jul 1, 2025 07:00AM
May 28, 2025 08:00AM
May 13, 2025 04:05PM
May 7, 2025 08:00AM
Apr 30, 2025 08:00AM Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York
Apr 7, 2025 08:00AM
Apr 2, 2025 04:07PM
Apr 2, 2025 04:05PM
Mar 31, 2025 08:00AM
Mar 26, 2025 07:02AM
Mar 26, 2025 07:00AM
Mar 11, 2025 04:05PM Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Mar 3, 2025 07:00AM

322,879 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All